ArticleClinical & translational immunology2021

Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.

Rebecca C Abbott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.